Compare Bath & Body Works Inc (BBWI) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Moderna, Inc. — how do they compare? Bath & Body Works Inc trades at $18.9 (market cap $3.89B), while Moderna, Inc. trades at $60.83 (market cap $23.88B). The key difference: Moderna, Inc. is far larger — about 6.1× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays a 4.14% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| BBWI | MRNA | |
|---|---|---|
Market Cap | $3.89B | $23.88B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $81.80 |
52-Week Low | $14.85 | $22.36 |
Enterprise Value | $7.79B | $20.03B |
Dividend Yield | 4.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
